뇌하수체암 시장 : 암 유형별, 호르몬 유형별, 치료 유형별, 연령층별, 최종 사용자별, 지역별

Pituitary Cancer Market, By Cancer Type, By Hormone Type, By Treatment Type, By Age Group, By End User, By Geography

US $ 4,500 ￦ 6,195,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 7,000 ￦ 9,636,000

PDF (Multi User License)

PDF 보고서를 동일 사업장에서 7명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 10,000 ￦ 13,767,000

PDF (Enterprise User License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

뇌하수체암 시장은 2025년에는 4억 5,770만 달러로 추정되고, 2032년에는 8억 6,950만 달러에 이를 것으로 예측되며, 2025년부터 2032년에 걸쳐 CAGR 9.6%를 나타낼 것으로 전망됩니다.

보고 범위		보고서 세부정보
기준 연도	2024년	시장 규모(2025년)	4억 5,770만 달러
실적 데이터	2020-2024년	예측 기간	2025-2032년
예측 기간 : 2025-2032년 CAGR :	9.60%	가치 예측(2032년)	8억 6,950만 달러

뇌하수체암의 원인은 잘 알려져 있지 않습니다. 그러나 유전학 및 호르몬 불균형이 한 역할을 하고 있을 가능성이 있습니다. 뇌하수체 종양의 대부분은 선종, 즉 비암성입니다.

뇌하수체암의 증상은 종종 두통, 시력의 변화, 체중 감소 또는 체중 증가 불능, 기억력과 집중력의 저하 등이 있습니다. 프로락틴이 과잉으로 분비되어 가슴이나 팔의 피부가 얇아지거나 발 허리의 뼈가 약해지거나 하는 경우도 있습니다. 또, 임신하지 않아도 유방으로부터 유즙이 분비되는 경우도 있습니다. 또, 얼굴이 붉어지거나 팔이나 다리의 혈압이 높아지는 등, 혈압에 다양한 변화를 일으키는 일도 있습니다.

시장 역학 :

뇌하수체 종양의 발생률 상승, 연구 개발 활동에 대한 투자 증가, 치료법의 기술적 진보가 예측 기간 중 세계의 뇌하수체암 시장 성장을 가속할 것으로 전망됩니다.

그러나 암치료비의 높이는 예측기간에 걸쳐 세계의 뇌하수체암 시장 성장을 저해할 것으로 예상되는 주요인입니다.

본 조사의 주요 특징

• 본 보고서에서는 세계의 뇌하수체암 시장을 상세하게 분석하여 2024년을 기준연도로 한 예측기간 2025-2032년 시장 규모 및 복합연간 성장률(CAGR%)을 제공합니다.
• 또, 다양한 부문에 걸친 잠재적인 수익 기회를 해명해, 이 시장의 매력적인 투자 제안 매트릭스를 해설했습니다.
• 또 시장 성장 촉진요인, 억제요인, 기회, 신제품의 상시나 승인, 시장 동향, 지역별 전망, 주요 기업이 채용하는 경쟁 전략 등에 관한 중요한 인사이트도 제공합니다.
• 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 실적, 전략 등의 파라미터에 근거해, 세계의 뇌하수체암 시장 주요 기업 프로파일을 제공합니다.
• 본 보고서로부터의 인사이트에 의해 마케팅 담당자나 기업의 경영진은 향후 제품 발매, 유형 업그레이드, 시장 확대, 마케팅 전술에 관한 정보에 근거한 의사 결정을 실시할 수 있게 됩니다.
• 세계의 뇌하수체암 시장 보고서는 투자자, 공급업체, 제품 제조업체, 판매자, 신규 참가자, 재무 분석가 등이 업계의 다양한 이해 관계자에 대응하고 있습니다.
• 이해관계자는 세계의 뇌하수체암 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정이 용이해집니다.

목차

제1장 조사의 목적과 전제조건

• 조사 목적
• 전제조건
• 약어

제2장 시장 전망

• 보고서 설명
  • 시장 정의 및 범위
• 주요 요약
• 일관된 기회 맵(COM)

제3장 시장 역학, 규제, 동향 분석

• 시장 역학
  • 성장 촉진요인
• 발생률과 유병률 증가
• 의료 영상 진단의 진보
• 연구개발 강화
• 맞춤형 의료 수요 증가
  • 성장 억제요인
• 인식 부족과 진단 지연
• 표준화된 치료 지침의 부족
• 진행성 뇌하수체암의 제한된 치료 옵션
• 의약품 개발의 과제
  • 기회
• 표적 치료의 개발
• 병용 요법
• 수술 기술의 진보
• 새로운 화상 진단법의 개발
• 영향 분석
• 주요 하이라이트
• 규제 시나리오
• 제품 출시/승인
• PEST 분석
• PORTER 분석
• 합병과 인수 시나리오

제4장 뇌하수체암 시장 - 코로나바이러스(COVID-19) 팬데믹의 영향

• COVID-19 역학
• 공급측과 수요측의 분석
• 경제에 미치는 영향

제5장 뇌하수체암 시장, 암 유형별(2020-2032년)

• 뇌하수체 선종(양성 종양)
• 뇌하수체 암종(악성 종양)

제6장 뇌하수체암 시장, 호르몬 유형별(2020-2032년)

• 프로락틴 종
• 성장 호르몬 분비 종양(말단 비대증)
• 부신피질 자극 호르몬 분비 종양(쿠싱병)
• 갑상선 자극 호르몬 분비 종양(TSHoma)
• 성선 자극 호르몬 분비 종양

제7장 뇌하수체암 시장, 치료 유형별(2020-2032년)

• 수술
• 방사선 치료
• 약물(예 : 도파민 작용제, 소마토스타틴 유사체, 호르몬 보충 요법)
• 표적 치료
• 화학 치료

제8장 뇌하수체암 시장, 연령별(2020-2032년)

• 소아
• 성인

제9장 뇌하수체암 시장, 최종 사용자별(2020-2032년)

• 병원
• 전문 클리닉
• 암 치료 센터
• 연구기관

제10장 뇌하수체암 시장, 지역별(2020-2032년)

• 북미
• 미국
• 캐나다
• 유럽
• 영국
• 독일
• 이탈리아
• 프랑스
• 스페인
• 러시아
• 기타 유럽
• 아시아태평양
• 중국
• 인도
• 일본
• ASEAN
• 호주
• 한국
• 기타 아시아태평양
• 라틴아메리카
• 브라질
• 멕시코
• 아르헨티나
• 기타 라틴아메리카
• 중동 및 아프리카
• GCC
• 이스라엘
• 북아프리카
• 중앙아프리카
• 기타 중동 및 아프리카

제11장 경쟁 구도

• Novartis International AG
• Pfizer Inc.
• Ipsen Biopharmaceuticals, Inc.
• Endocyte
• RECORDATI GROUP
• Camurus AB
• Endeavor Biomedicines, Inc
• Debiopharm International SA

제12장 섹션

• 조사 방법
• 출판사에 대해

KTH

영문 목차

영문목차

Pituitary Cancer Market is estimated to be valued at USD 457.7 Mn in 2025 and is expected to reach USD 869.5 Mn by 2032, growing at a compound annual growth rate (CAGR) of 9.6% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 457.7 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	9.60%	2032 Value Projection:	USD 869.5 Mn

The cause of pituitary cancer is not well understood. But genetics and hormonal imbalances may play a role. Most pituitary tumors are adenomas, or noncancerous. They are not as common as pituitary gland cysts, which are benign (noncancerous).

Symptoms of pituitary cancer often include headaches, vision changes, loss of weight or an inability to gain weight, and trouble with memory and concentration. Some types of pituitary tumors release too many hormones, which can lead to a disease called Cushing's syndrome. In some cases, this disease causes the body to produce too much prolactin, which can cause thinning of the skin in the chest and arms, and weak bones in the legs and feet. Other forms of this condition can cause the breasts to make milk, even when the person is not pregnant. The condition can also cause a wide range of changes in blood pressure, including a flushed face and high blood pressure in the arms or legs.

Market Dynamics:

Rising incidences of pituitary tumors, increasing investments in research and development activities, and technological advancements in treatment methods are expected to drive growth of the global pituitary cancer market during the forecast period. In addition, increased awareness among the populace has led to a higher demand for noninvasive treatments. The market is also driven by a rise in the number of hospitals and clinics that offer specialized services for pituitary tumors.

However, the high cost of cancer treatments is a major factor expected to impede the growth of the global pituitary cancer market over the forecast period.

Key features of the study:

• This report provides in-depth analysis of the global pituitary cancer market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global pituitary cancer market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Novartis International AG, Pfizer Inc., Ipsen Biopharmaceuticals, Inc., Endocyte, RECORDATI GROUP, Camurus AB, Endeavor Biomedicines, Inc., and Debiopharm International SA
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global pituitary cancer market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pituitary cancer market

Global Pituitary Cancer Market Detailed Segmentation:

• By Cancer Type:
  • Pituitary Adenoma (Benign Tumor)
  • Pituitary Carcinoma (Malignant Tumor)
• By Hormone Type:
  • Prolactinoma
  • Growth Hormone-Secreting Tumor (Acromegaly)
  • Adrenocorticotropic Hormone-Secreting Tumor (Cushing's Disease)
  • Thyroid-Stimulating Hormone-Secreting Tumor (TSHoma)
  • Gonadotropin-Secreting Tumor
• By Treatment Type:
  • Surgery
  • Radiation Therapy
  • Medications (e.g., dopamine agonists, somatostatin analogs, hormone replacement therapy)
  • Targeted Therapy
  • Chemotherapy
• By Age Group:
  • Pediatric
  • Adult
• By End User:
  • Hospitals
  • Specialty Clinics
  • Cancer Treatment Centers
  • Research Institutes
• By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
• Company Profile:
  • Novartis International AG
  • Pfizer Inc.
  • Ipsen Biopharmaceuticals, Inc.
  • Endocyte
  • RECORDATI GROUP
  • Camurus AB
  • Endeavor Biomedicines, Inc.
  • Debiopharm International SA

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Pituitary Cancer, By Cancer Type
  • Market Pituitary Cancer, By Hormone Type
  • Market Pituitary Cancer, By Treatment Type
  • Market Pituitary Cancer, By Age Group
  • Market Pituitary Cancer, By End User
  • Market Pituitary Cancer, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
• Increasing Incidence and Prevalence
• Advancements in Medical Imaging and Diagnostics
• Increased Research and Development
• Growing Demand for Personalized Medicine
  • Restraints
• Limited Awareness and Delayed Diagnosis
• Lack of Standardized Treatment Guidelines
• Limited Treatment Options for Aggressive Pituitary Cancers
• Challenges in Drug Development
  • Opportunities
• Development of Targeted Therapies
• Combination Therapies
• Advancements in Surgical Techniques
• Development of Novel Imaging Modalities
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product launch/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Pituitary Cancer Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Pituitary Cancer Market, By Cancer Type, 2020-2032, (US$ Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021-2032
  • Segment Trends
• Pituitary Adenoma (Benign Tumor)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Pituitary Carcinoma (Malignant Tumor)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

6. Pituitary Cancer Market, By Hormone Type, 2020-2032, (US$ Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021-2032
  • Segment Trends
• Prolactinoma
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)
• Growth Hormone-Secreting Tumor (Acromegaly)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)
• Adrenocorticotropic Hormone-Secreting Tumor (Cushing's Disease)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)
• Thyroid-Stimulating Hormone-Secreting Tumor (TSHoma)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)
• Gonadotropin-Secreting Tumor
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)

7. Pituitary Cancer Market, By Treatment Type, 2020-2032, (US$ Mn)

• Introduction
  • Market Share Analysis, 2023and 2032 (%)
  • Y-o-Y Growth Analysis, 2021- 2032
  • Segment Trends
• Surgery
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)
• Radiation Therapy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)
• Medications(e.g., dopamine agonists, somatostatin analogs, hormone replacement therapy)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)
• Targeted Therapy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)
• Chemotherapy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)

8. Pituitary Cancer Market, By Age Group, 2020-2032, (US$ Mn)

• Introduction
  • Market Share Analysis, 2023and 2032 (%)
  • Y-o-Y Growth Analysis, 2021-2032
  • Segment Trends
• Pediatric
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)
• Adult
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)

9. Pituitary Cancer Market, By End User, 2020-2032, (US$ Mn)

• Introduction
  • Market Share Analysis, 2023and 2032 (%)
  • Y-o-Y Growth Analysis, 2021-2032
  • Segment Trends
• Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)
• Specialty Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)
• Cancer Treatment Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)
• Research Institutes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)

10. Pituitary Cancer Market, By Region, 2020-2032, (US$ Mn)

• Introduction
  • Market Share Analysis, By Country, 2023and 2032 (%)
  • Y-o-Y Growth Analysis, For Country 2021-2032
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Hormone Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
• U.S.
• Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Hormone Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
• U.K.
• Germany
• Italy
• France
• Spain
• Russia
• Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Hormone Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
• China
• India
• Japan
• ASEAN
• Australia
• South Korea
• Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Hormone Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Middle East & Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Hormone Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
• GCC
• Israel
• North Africa
• Central Africa
• Rest of Middle East & Africa

11. Competitive Landscape

• Novartis International AG
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Pfizer Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Ipsen Biopharmaceuticals, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Endocyte
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• RECORDATI GROUP
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Camurus AB
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Endeavor Biomedicines, Inc
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Debiopharm International SA
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Analyst Views

12. Section

• Research Methodology
• About us

관련자료